Treace Medical Concepts, Inc. Interest Expense
Treace Medical Concepts, Inc. (TMCI) reported Interest Expense of $1.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2026-08-07
- Treace Medical Concepts, Inc. interest expense for the quarter ending 2026-06-30 was $1.56M, a 18.24% increase year-over-year.
- Treace Medical Concepts, Inc. interest expense for the quarter ending 2026-03-31 was $1.57M, a 19.76% increase year-over-year.
- Treace Medical Concepts, Inc. interest expense for the quarter ending 2025-12-31 was $1.35M, a 2.74% increase year-over-year.
- Treace Medical Concepts, Inc. interest expense for the quarter ending 2025-09-30 was $1.34M, a 1.90% increase year-over-year.
- Treace Medical Concepts, Inc. interest expense for fiscal 2023 was $5.17M, a 17.49% increase from fiscal 2022.
- Treace Medical Concepts, Inc. interest expense for fiscal 2022 was $4.40M, a 8.33% increase from fiscal 2021.
- Treace Medical Concepts, Inc. interest expense for fiscal 2021 was $4.06M, a 46.20% increase from fiscal 2020.
- Treace Medical Concepts, Inc. interest expense for fiscal 2020 was $2.78M, a 230.20% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.56M 10-Q · filed 2026-08-07 | $3.13M 10-Q · filed 2026-08-07 | $4.48M derived: sum of 3 quarters · filed 2026-08-07 | $5.82M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.57M 10-Q · filed 2026-05-08 | $2.92M derived: sum of 2 quarters · filed 2026-05-08 | $4.26M derived: sum of 3 quarters · filed 2026-05-08 | $5.58M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.35M DEF 14A · filed 2026-04-06 | $2.69M derived: sum of 2 quarters · filed 2026-04-06 | $4.01M derived: sum of 3 quarters · filed 2026-08-07 | $5.32M DEF 14A · filed 2026-04-06 |
| 2025-09-30 | $1.34M 10-Q · filed 2025-11-06 | $2.66M derived: sum of 2 quarters · filed 2026-08-07 | $3.97M 10-Q · filed 2025-11-06 | $5.28M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.32M 10-Q · filed 2026-08-07 | $2.63M 10-Q · filed 2026-08-07 | $3.95M derived: sum of 3 quarters · filed 2026-08-07 | $5.26M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.31M 10-Q · filed 2026-05-08 | $2.63M derived: sum of 2 quarters · filed 2026-05-08 | $3.94M derived: sum of 3 quarters · filed 2026-05-08 | $5.25M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.31M DEF 14A · filed 2026-04-06 | $2.63M derived: sum of 2 quarters · filed 2026-04-06 | $3.94M derived: sum of 3 quarters · filed 2026-04-06 | $5.26M DEF 14A · filed 2026-04-06 |
| 2024-09-30 | $1.31M 10-Q · filed 2025-11-06 | $2.63M derived: sum of 2 quarters · filed 2025-11-06 | $3.94M 10-Q · filed 2025-11-06 | $5.25M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.31M 10-Q · filed 2025-08-07 | $2.63M 10-Q · filed 2025-08-07 | $3.93M derived: sum of 3 quarters · filed 2026-02-27 | $5.23M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $1.32M 10-Q · filed 2025-05-08 | $2.62M derived: sum of 2 quarters · filed 2026-02-27 | $3.92M derived: sum of 3 quarters · filed 2026-02-27 | $5.20M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.60M derived: sum of 2 quarters · filed 2026-02-27 | $3.88M derived: sum of 3 quarters · filed 2026-02-27 | $5.17M 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.30M 10-Q · filed 2024-11-05 | $2.58M derived: sum of 2 quarters · filed 2024-11-05 | $3.86M 10-Q · filed 2024-11-05 | $5.17M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.28M 10-Q · filed 2024-08-06 | $2.57M 10-Q · filed 2024-08-06 | $3.88M derived: sum of 3 quarters · filed 2025-02-27 | $5.07M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.28M 10-Q · filed 2024-05-07 | $2.60M derived: sum of 2 quarters · filed 2025-02-27 | $3.79M derived: sum of 3 quarters · filed 2025-02-27 | $4.73M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.50M derived: sum of 2 quarters · filed 2025-02-27 | $3.45M derived: sum of 3 quarters · filed 2025-02-27 | $4.40M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.19M 10-Q · filed 2023-11-09 | $2.14M derived: sum of 2 quarters · filed 2023-11-09 | $3.09M 10-Q · filed 2023-11-09 | $4.12M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $946.00K 10-Q · filed 2023-08-09 | $1.90M 10-Q · filed 2023-08-09 | $2.92M derived: sum of 3 quarters · filed 2024-02-27 | $3.89M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $951.00K 10-Q · filed 2023-05-09 | $1.98M derived: sum of 2 quarters · filed 2024-02-27 | $2.94M derived: sum of 3 quarters · filed 2024-02-27 | $3.98M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.99M derived: sum of 2 quarters · filed 2024-02-27 | $3.03M derived: sum of 3 quarters · filed 2024-02-27 | $4.06M 10-K · filed 2024-02-27 |
| 2021-09-30 | $963.00K 10-Q · filed 2022-11-09 | $2.00M derived: sum of 2 quarters · filed 2022-11-09 | $3.03M 10-Q · filed 2022-11-09 | $4.10M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $1.04M 10-Q · filed 2022-08-10 | $2.07M 10-Q · filed 2022-08-10 | $3.14M derived: sum of 3 quarters · filed 2023-03-08 | $3.95M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | $1.03M 10-Q · filed 2022-05-06 | $2.10M derived: sum of 2 quarters · filed 2023-03-08 | $2.91M derived: sum of 3 quarters · filed 2023-03-08 | $3.37M derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $1.88M derived: sum of 2 quarters · filed 2023-03-08 | $2.34M derived: sum of 3 quarters · filed 2023-03-08 | $2.78M 10-K · filed 2023-03-08 |
| 2020-09-30 | $808.00K 10-Q · filed 2021-11-04 | $1.27M derived: sum of 2 quarters · filed 2021-11-04 | $1.71M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $458.00K 10-Q · filed 2021-08-05 | $899.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $441.00K 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | $841.00K 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |